Evidence map›Paper›PMID 40362280›Full record

ReviewInternational journal of molecular sciences2025

From Defense to Disease: How the Immune System Fuels Epithelial-Mesenchymal Transition in Ovarian Cancer.

Michał Kos, Paulina Mertowska, Sebastian Mertowski, Jacek Roliński, Aleksandra Krasińska-Płachta, Tomasz Urbanowicz, Marek Gogacz, Ewelina Grywalska

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Michał KosII Clinic of Gynecology, Medical University of Lublin, 20-093 Lublin, Poland.
Paulina MertowskaDepartment of Experimental Immunology, Medical University of Lublin, 20-093 Lublin, Poland.ORCID 0000-0001-9530-6659
Sebastian MertowskiDepartment of Experimental Immunology, Medical University of Lublin, 20-093 Lublin, Poland.ORCID 0000-0002-7121-1396
Jacek RolińskiDepartment of Clinical Immunology, Medical University of Lublin, 4a Chodźki Street, 20-093 Lublin, Poland.
Aleksandra Krasińska-PłachtaDepartment of Ophthalmology, Poznan University of Medical Sciences, Fredry 10, 61-107 Poznan, Poland.
Tomasz UrbanowiczCardiac Surgery and Transplantology Department, Poznan University of Medical Sciences, 61-848 Poznan, Poland.ORCID 0000-0001-8080-2764
Marek GogaczII Clinic of Gynecology, Medical University of Lublin, 20-093 Lublin, Poland.
Ewelina GrywalskaDepartment of Experimental Immunology, Medical University of Lublin, 20-093 Lublin, Poland.ORCID 0000-0002-0451-4741

Funding

Poznan University of Medical Sciences
6 · The paper itself

Abstract

Ovarian cancer is one of the most deadly gynecological cancers, with over 300 thousand new cases per year, most of which are diagnosed in advanced stages. The limited availability of effective biomarkers and lack of characteristic symptoms make early diagnosis difficult, resulting in a five-year survival rate of 30-40%. Mutations in the

Indexed as

Epithelial-Mesenchymal TransitionImmune SystemOvarian NeoplasmsAnimalsBiomarkers, TumorCytokinesFemaleHumansSignal TransductionTumor MicroenvironmentBiomarkers, TumorCytokinescancerEMTimmune systemoncogenesisoncologyprognostic factors

Identifiers

PMID40362280
PMCPMC12072087

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.